Selecting treatment for hepatocellular carcinoma based on the results of hepatic resection and local ablation therapy
β Scribed by Atsushi Nanashima; Syuuichi Tobinaga; Junichi Masuda; Hisamitsu Miyaaki; Naota Taura; Hiroaki Takeshita; Shigekazu Hidaka; Terumitsu Sawai; Kazuhiko Nakao; Takeshi Nagayasu
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 128 KB
- Volume
- 101
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background. Because transcatheter arterial embolization (TAE) has been shown to be effective in patients with unresectable hepatocellular carcinoma (HCC), the question arises whether TAE has an equivalent or superior effect on resectable HCC compared with surgery. To clarify this point, the authors
## Abstract ## Background and Objectives The recurrence of hepatocellular carcinoma (HCC) after percutaneous ablation is poorly evaluated. ## Methods Thirtyβsix cases of recurrence after percutaneous ablation (PA) (Group 1) are compared to those after surgery, treated with reβresection (26 patie
The Commission on Cancer data from the National Cancer Data Base (NCDB) has previously reported data evaluating time trends in various cancers, including such elements as stage of disease at diagnosis, treatment, and survival for multiple tumor sites. In this report, data collected from 1985, 1986,